Follow the entities shaping the evidence.

…, and 21% three biological drugs.Before starting treatment with tezepelumab, 89% of patients received oral corticosteroids (OCS) as mainten…

…n has become a preferred therapeutic option over vancomycin for Clostridioides difficile infection, particularly in patients at high risk of recurrence.…

…roup (88.6% vs 63%).SR related complications were higher in the midazolam group: agitation (50% vs 47,8%), delirium (25% vs 4,3%), hypote…

…. The median number of prior treatment lines was four. Prior to fruquintinib, 22 patients had received TAS-102 plus bevacizumab, eight recei…

…bidities were dyslipidaemia (10.64%), hypertension (4.26%), and diabetes (4.26%). 12% percent had nephropathy before starting PrEP. Seru…

…ed. The most frequent interventions were discontinuation of the index medication followed by introducing additional medication to treat the ADR …

…receiving durvalumab, 25% receiving cemiplimab, 66.7% receiving avelumab, and 60% receiving the ipilimumab and nivolumab. A 61.5% of irA…

…as recorded in 14 off-label cases.Conclusion and Relevance Most IVIg prescriptions were in line with approved indications, possibly …

…es, affecting both sexes similarly.Among discharge medications, aspirin (96.14% in men vs. 95.5% in women; p=1) and statins (98.7% vs. …

…Pharmacotherapeutic group most frequently associated with PIMs: proton pump inhibitors 64 (11.7%) and vitamins 49 (9.0%).Conclusion and Relevance Near…

…Background and Importance Syringe replacement during norepinephrine administration is a critical process and may cause hemodynamic …

…obtained from 29 patients (72% male, mean age 56,2±20,1 years). Tobramycin (300 mg/12 h) showed systemic absorption (Cp_tobra > 0,1µg/mL) …